Back to search
Solitary Bone Plasmacytoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Solitary Bone Plasmacytoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Solitary Bone Plasmacytoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a prospective, single-arm, single-center clinical trial designed to evaluate the safety and efficacy of radiation combined with a BCMA/CD3 bispecific an…
All subjects will receive GR1803 injection until intolerable toxicity or investigator-assessed disease progression occurs (except in cases of disease progressio…
Solitary Plasmacytoma (SP) is a rare malignant plasma cell tumor, including Solitary Bone Plasmacytoma (SBP) and Solitary Extramedullary Plasmacytoma (SEP). Rad…
Solitary plasmacytoma (SP) is characterized by a localized mass of clonal plasma cells with no or minimal bone marrow plasmacytosis. It can present either as EM…
This randomized phase III trial compares ixazomib citrate, lenalidomide, dexamethasone and zoledronic acid with zoledronic acid alone to see how well they work…
It is essential to improve clinical efficiency and management of hematological and oncological patients treated on an outpatient basis. The most promising opera…